Risk factors associated with distant metastasis in patients with oral squamous cell carcinoma

Otolaryngology - Head and Neck Surgery (United States)

Volumn 152, Issue 6, 2015, Pages 1053-1060

  Hasegawa, Takumi ^a   Tanakura, Makiko ^a   Takeda, Daisuke ^a   Sakakibara, Akiko ^a   Akashi, Masaya ^a   Minamikawa, Tsutomu ^a   Komori, Takahide ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

distant metastasis; oral cancer; oral squamous cell carcinoma; risk factor

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT CHEMORADIOTHERAPY; ADULT; AGED; ARTICLE; BONE METASTASIS; BRAIN METASTASIS; CANCER PATIENT; CANCER STAGING; CASE STUDY; DISTANT METASTASIS; FEMALE; HUMAN; INCIDENCE; LUNG METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MIDDLE AGED; MOUTH SQUAMOUS CELL CARCINOMA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POSTOPERATIVE CARE; RETROSPECTIVE STUDY; RISK FACTOR; SKIN METASTASIS; SURVIVAL RATE; TERTIARY CARE CENTER; TREATMENT FAILURE; TUMOR INVASION; CARCINOMA, SQUAMOUS CELL; COHORT ANALYSIS; DISEASE FREE SURVIVAL; IMMUNOHISTOCHEMISTRY; JAPAN; LYMPH NODE DISSECTION; METASTASIS; MORTALITY; MOUTH NEOPLASMS; MULTIVARIATE ANALYSIS; NECK DISSECTION; NEEDLE BIOPSY; PATHOLOGY; PROCEDURES; PROGNOSIS; RISK; SECONDARY; STATISTICAL MODEL; SURVIVAL; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; JAPAN; LOGISTIC MODELS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; MULTIVARIATE ANALYSIS; NECK DISSECTION; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM STAGING; ODDS RATIO; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 84930411947     PISSN: 01945998     EISSN: 10976817     Source Type: Journal    
DOI: 10.1177/0194599815580980     Document Type: Article

References (39)

1. Rose BS, Jeong JH, Nath SK, Lu SM, Mell LK. Population-based study of competing mortality in head and neck cancer. J Clin Oncol. 2011 ; 29: 3503-3509
2. Liao CT, Chang JT, Wang HM, et al. Analysis of risk factors of predictive local tumor control in oral cavity cancer. Ann Surg Oncol. 2008 ; 15: 915-922
3. Liao CT, Wang HM, Chang JT, et al. Analysis of risk factors for distant metastases in squamous cell carcinoma of the oral cavity. Cancer. 2007 ; 110: 1501-1508
4. Hong WK, Bromer RH, Amato DA, et al. Patterns of relapse in locally advanced head and neck cancer patients who achieved complete remission after combined modality therapy. Cancer. 1985 ; 56: 1242-1245
5. León X, Quer M, Orús C, del Prado Venegas M, López M. Distant metastases in head and neck cancer patients who achieved loco-regional control. Head Neck. 2000 ; 22: 680-686
6. Ferlito A, Shaha AR, Silver CE, Rinaldo A, Mondin V. Incidence and sites of distant metastases from head and neck cancer. ORL J Otorhinolaryngol Relat Spec. 2001 ; 63: 202-207
7. Garavello W, Ciardo A, Spreafico R, Gaini RM. Risk factors for distant metastases in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 2006 ; 132: 762-766
8. Li X, Di B, Shang Y, Zhou Y, Cheng J, He Z. Clinicopathologic risk factors for distant metastases from head and neck squamous cell carcinomas. Eur J Surg Oncol. 2009 ; 35: 1348-1353
9. Calhoun KH, Fulmer P, Weiss R, Hokanson JA. Distant metastases from head and neck squamous cell carcinomas. Laryngoscope. 1994 ; 104: 1199-1205
10. Troell RJ, Terris DJ. Detection of metastases from head and neck cancers. Laryngoscope. 105: 247-250
11. Lim YC, Koo BS, Choi EC. Bilateral neck node metastasis: a predictor of isolated distant metastasis in patients with oral and oropharyngeal squamous cell carcinoma after primary curative surgery. Laryngoscope. 2007 ; 117: 1576-1580
12. Shingaki S, Suzuki I, Kobayashi T, Nakajima T. Predicting factors for distant metastases in head and neck carcinomas: an analysis of 103 patients with locoregional control. J Oral Maxillofac Surg. 1996 ; 54: 853-857
13. Myers JN, Greenberg JS, Mo V, Roberts D. Extracapsular spread: a significant predictor of treatment failure in patients with squamous cell carcinoma of the tongue. Cancer. 2001 ; 92: 3030-3036
14. Fortin A, Couture C, Doucet R, Albert M, Allard J, Tetu B. Does histologic grade have a role in the management of head and neck cancers?. J Clin Oncol. 2001 ; 19: 4107-4116
15. Lim JY, Lim YC, Kim SH, Kim JW, Jeong HM, Choi EC. Predictive factors of isolated distant metastasis after primary definitive surgery without systemic treatment for head and neck squamous cell carcinoma. Oral Oncol. 2010 ; 46: 504-508
16. Sumioka S, Sawai NY, Kishino M, Ishihama K, Minami M, Okura M. Risk factors for distant metastasis in squamous cell carcinoma of the oral cavity. J Oral Maxillofac Surg. 2013 ; 71: 1291-1297
17. Chen TC, Hsu CW, Lou PJ, et al. The clinical predictive factors for subsequent distant metastasis in patients with locoregionally advanced oral squamous cell carcinoma. Oral Oncol. 2013 ; 49: 367-373
18. Jerjes W, Upile T, Petrie A, et al. Clinicopathological parameters, recurrence, locoregional and distant metastasis in 115 T1-T2 oral squamous cell carcinoma patients. Head Neck Oncol. 2010 ; 2: 9
19. Huang CG, Lee LA, Tsao KC, et al. Human papillomavirus 16/18 E7 viral loads predict distant metastasis in oral cavity squamous cell carcinoma. J Clin Virol. 2014 ; 61: 230-236
20. Po Wing Yuen A, Lam KY, Lam LK, et al. Prognostic factors of clinically stage I and II oral tongue carcinoma: a comparative study of stage, thickness, shape, growth pattern, invasive front malignancy grading, Martinez-Gimeno score, and pathologic features. Head Neck. 2002 ; 24: 513-520
21. O-charoenrat P, Pillai G, Patel S, et al. Tumour thickness predicts cervical nodal metastases and survival in early oral tongue cancer. Oral Oncol. 2003 ; 39: 386-390
22. Kademani D, Bell RB, Bagheri S, et al. Prognostic factors in intraoral squamous cell carcinoma: the influence of histologic grade. J Oral Maxillofac Surg. 2005 ; 63: 1599-1605
23. Bernier J, Cooper JS, Pajak TF, et al. Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501). Head Neck. 2005 ; 27: 843-850
24. Kowalski LP, Carvalho AL, Martins Priante AV, Magrin J. Predictive factors for distant metastasis from oral and oropharyngeal squamous cell carcinoma. Oral Oncol. 2005 ; 41: 534-541
25. A phase III randomised trial of cisplatinum, methotrextate, cisplatinum + methotrexate and cisplatinum + 5- FU in end stage squamous carcinoma of the head and neck. Br J Cancer. 1990 ; 61: 311-315
26. Jacobs C, Lyman G, Velez-García E, et al. A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck. J Clin Oncol. 1992 ; 10: 257-263
27. Forastiere AA, Metch B, Schuller DE, et al. Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a southwest oncology group study. J Clin Oncol. 1992 ; 10: 1245-1251
28. Gibson MK, Li Y, Murphy B, et al. Randomized phase III evaluation of cisplatin plus fluorouracil versus cisplatin plus paclitaxel in advanced head and neck cancer (E1395): an intergroup trial of the Eastern Cooperative Oncology Group. J Clin Oncol. 2005 ; 23: 3562-3567
29. Forastiere AA, Leong T, Rowinsky E, et al. Phase III comparison of high-dose paclitaxel + cisplatin + granulocyte colony-stimulating factor versus low-dose paclitaxel + cisplatin in advanced head and neck cancer: Eastern Cooperative Oncology Group study E1393. J Clin Oncol. 2001 ; 19: 1088-1095
30. Laramore GE, Scott CB, al-Sarraf M, et al. Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: report on Intergroup Study 0034. Int J Radiat Oncol Biol Phys. 1992 ; 23: 705-713
31. Bachaud JM, Cohen-Jonathan E, Alzieu C, David JM, Serrano E, Daly-Schveitzer N. Combined postoperative radiotherapy and weekly cisplatin infusion for locally advanced head and neck carcinoma: final report of a randomized trial. Int J Radiat Oncol Biol Phys. 1996 ; 36: 999-1004
32. Slotman GJ, Mohit T, Raina S, Swaminathan AP, Ohanian M, Rush BF. The incidence of metastases after multimodal therapy for cancer of the head and neck. Cancer. 1984 ; 54: 2009-2014
33. Baselga J, Trigo JM, Bourhis J, et al. Phase II multicenter study of the antiepidermal growth factor receptor monoclonal antibody cetuximab in combination with platinum-based chemotherapy in patients with platinum refractory metastatic and/or recurrent squamous cell carcinoma of the head and neck. J Clin Oncol. 2005 ; 23: 5568-5577
34. Vermorken JB, Trigo J, Hitt R, et al. Open-label, uncontrolled, multicenter phase II study to evaluate the efficacy and toxicity of cetuximab as a single agent in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck who failed to respond to platinum-based therapy. J Clin Oncol. 2007 ; 25: 2171-2177
35. Shiono S, Kawamura M, Sato T, et al. Metastatic Lung Tumor Study Group of Japan. Pulmonary metastasectomy for pulmonary metastases of head and neck squamous cell carcinomas. Ann Thorac Surg. 2009 ; 88: 856-860
36. Mazer TM, Robbins KT, McMurtrey MJ, Byers RM. Resection of pulmonary metastases from squamous carcinoma of the head and neck. Am J Surg. 1988 ; 156: 238-242
37. Wedman J, Balm AJ, Hart AA, et al. Value of resection of pulmonary metastases in head and neck cancer patients. Head Neck. 1996 ; 18: 311-316
38. Nibu K, Nakagawa K, Kamata S, et al. Surgical treatment for pulmonary metastases of squamous cell carcinoma of the head and neck. Am J Otolaryngol. 1997 ; 18: 391-395
39. Finley RK, Verazin GT, Driscoll DL, et al. Results of surgical resection of pulmonary metastases of squamous cell carcinoma of the head and neck. Am J Surg. 1992 ; 164: 594-598